Literature DB >> 22074671

Statistical issues with the analysis of nonrandomized studies in comparative effectiveness research.

Demissie Alemayehu1, Jose Ma J Alvir, Byron Jones, Richard J Willke.   

Abstract

Mesh:

Year:  2011        PMID: 22074671     DOI: 10.18553/jmcp.2011.17.s9-a.S22

Source DB:  PubMed          Journal:  J Manag Care Pharm        ISSN: 1083-4087


× No keyword cloud information.
  6 in total

Review 1.  Methods to control for unmeasured confounding in pharmacoepidemiology: an overview.

Authors:  Md Jamal Uddin; Rolf H H Groenwold; Mohammed Sanni Ali; Anthonius de Boer; Kit C B Roes; Muhammad A B Chowdhury; Olaf H Klungel
Journal:  Int J Clin Pharm       Date:  2016-04-18

2.  Prior event rate ratio adjustment for hidden confounding in observational studies of treatment effectiveness: a pairwise Cox likelihood approach.

Authors:  Nan Xuan Lin; William Edward Henley
Journal:  Stat Med       Date:  2016-08-01       Impact factor: 2.373

Review 3.  Adjusting for unmeasured confounding in nonrandomized longitudinal studies: a methodological review.

Authors:  Adam J Streeter; Nan Xuan Lin; Louise Crathorne; Marcela Haasova; Christopher Hyde; David Melzer; William E Henley
Journal:  J Clin Epidemiol       Date:  2017-04-28       Impact factor: 6.437

Review 4.  Relative Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor, Dacarbazine, and Glycoprotein 100 in Metastatic Melanoma: An Indirect Treatment Comparison.

Authors:  Casey Quinn; Qiufei Ma; Amber Kudlac; Stephen Palmer; Beth Barber; Zhongyun Zhao
Journal:  Adv Ther       Date:  2016-12-20       Impact factor: 3.845

5.  Indirect Treatment Comparison of Talimogene Laherparepvec Compared with Ipilimumab and Vemurafenib for the Treatment of Patients with Metastatic Melanoma.

Authors:  Casey Quinn; Qiufei Ma; Amber Kudlac; Stephen Palmer; Beth Barber; Zhongyun Zhao
Journal:  Adv Ther       Date:  2016-03-15       Impact factor: 3.845

6.  Prior event rate ratio adjustment produced estimates consistent with randomized trial: a diabetes case study.

Authors:  Lauren R Rodgers; John M Dennis; Beverley M Shields; Luke Mounce; Ian Fisher; Andrew T Hattersley; William E Henley
Journal:  J Clin Epidemiol       Date:  2020-03-17       Impact factor: 6.437

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.